This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Jeremy D. Young, MD, MPH
Advertisement
Articles by Jeremy D. Young, MD, MPH
Advertisement
Latest Updated Articles
New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 InfectionPublished: June 10th 2016 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
4
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
5
